PRKAA1 and metabolic dysfunction-associated steatohepatitis: A follow-up study showed that OCA significantly increased the phosphorylation levels of hepatic AMPK, reducing NASH pathologies, liver injury and apoptosis, and these OCA-mediated beneficial effects were largely abolished by the overexpression of miR-802 in dietary NASH mice26.